73 related articles for article (PubMed ID: 10852792)
21. Circadian basis of the late asthmatic response.
Mohiuddin AA; Martin RJ
Am Rev Respir Dis; 1990 Nov; 142(5):1153-7. PubMed ID: 2240837
[TBL] [Abstract][Full Text] [Related]
22. The links between allergen skin test sensitivity, airway responsiveness and airway response to allergen.
Cockcroft DW; Davis BE; Boulet LP; Deschesnes F; Gauvreau GM; O'Byrne PM; Watson RM
Allergy; 2005 Jan; 60(1):56-9. PubMed ID: 15575931
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation.
Gauvreau GM; Watson RM; O'Byrne PM
Am J Respir Crit Care Med; 1999 Aug; 160(2):640-7. PubMed ID: 10430741
[TBL] [Abstract][Full Text] [Related]
24. The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness.
Lai CK; Twentyman OP; Holgate ST
Am Rev Respir Dis; 1989 Oct; 140(4):917-23. PubMed ID: 2572192
[TBL] [Abstract][Full Text] [Related]
25. Perception of breathlessness during early and late asthmatic responses.
Turcotte H; Boulet LP
Am Rev Respir Dis; 1993 Aug; 148(2):514-8. PubMed ID: 8342918
[TBL] [Abstract][Full Text] [Related]
26. Discrepant nasal and bronchial nitric oxide kinetics during early and late phase allergic reactions.
Korn S; Beier J; Heilmann C; Kornmann O; Buhl R; Michael Beeh K
Respir Med; 2005 Dec; 99(12):1595-9. PubMed ID: 16291080
[TBL] [Abstract][Full Text] [Related]
27. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma.
Twentyman OP; Finnerty JP; Holgate ST
Am Rev Respir Dis; 1991 Oct; 144(4):782-7. PubMed ID: 1928949
[TBL] [Abstract][Full Text] [Related]
28. Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications.
Sumino K; Sugar EA; Irvin CG; Kaminsky DA; Shade D; Wei CY; Holbrook JT; Wise RA; Castro M;
J Allergy Clin Immunol; 2012 Jul; 130(1):69-75.e6. PubMed ID: 22465214
[TBL] [Abstract][Full Text] [Related]
29. Sputum inflammatory cells and allergen-induced airway responses in allergic asthmatic subjects.
Imaoka H; Gauvreau GM; Watson RM; Strinich T; Obminksi GL; Howie K; Killian KJ; O'Byrne PM
Allergy; 2011 Aug; 66(8):1075-80. PubMed ID: 21447082
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of sGaw, FEF(25-75), and FEV1 for development of asthma after a negative methacholine challenge test.
Khalid I; Obeid I; DiGiovine B; Khalid U; Morris ZQ
J Asthma; 2009 Apr; 46(3):284-90. PubMed ID: 19373638
[TBL] [Abstract][Full Text] [Related]
31. Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1).
De Meer G; Heederik D; Postma DS
Am J Respir Crit Care Med; 2002 Feb; 165(3):327-31. PubMed ID: 11818315
[TBL] [Abstract][Full Text] [Related]
32. Asymptomatic airway hyperresponsiveness: a three-year follow-up.
Laprise C; Boulet LP
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):403-9. PubMed ID: 9279216
[TBL] [Abstract][Full Text] [Related]
33. Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children.
Suh DI; Lee JK; Kim CK; Koh YY
Eur Respir J; 2011 Apr; 37(4):800-5. PubMed ID: 20817709
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[TBL] [Abstract][Full Text] [Related]
35. Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma.
Ottanelli R; Rosi E; Romagnoli I; Ronchi MC; Lanini B; Grazzini M; Filippelli M; Stendardi L; Duranti R; Scano G
Clin Sci (Lond); 2000 Jun; 98(6):681-7. PubMed ID: 10814605
[TBL] [Abstract][Full Text] [Related]
36. Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.
Diamant Z; Kuperus J; Baan R; Nietzmann K; Millet S; Mendes P; Miller B; Amin D; Rohatagi S; Sterk PJ; Hoogsteden HC; Prins JB
Clin Exp Allergy; 2005 Aug; 35(8):1080-7. PubMed ID: 16120091
[TBL] [Abstract][Full Text] [Related]
37. Benefits of induced sputum for the evaluation of therapeutic efficacy in patients with bronchial asthma.
Ohnishi H; Maeda H; Nishimura Y; Yokoyama M
Kobe J Med Sci; 1998 Aug; 44(4):149-61. PubMed ID: 10352494
[TBL] [Abstract][Full Text] [Related]
38. Sputum eosinophil counts and eosinophil cationic protein levels in cough-variant asthma and in classic asthma, and their relationships to airway hypersensitivity or maximal airway response to methacholine.
Yoo Y; Koh YY; Kang H; Yu J; Nah KM; Kim CK
Allergy; 2004 Oct; 59(10):1055-62. PubMed ID: 15355463
[TBL] [Abstract][Full Text] [Related]
39. Relationship of cellular transmigration and airway response after allergen challenge.
Ndukwu IM; Naureckas ET; Maxwell C; Waldman M; Leff AR
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1516-24. PubMed ID: 10556114
[TBL] [Abstract][Full Text] [Related]
40. β-2 agonists in sport: are the anti-doping rules meeting the needs of asthmatic athletes?
Orellana JN; Márquez MD
Br J Sports Med; 2011 Aug; 45(10):809-12. PubMed ID: 19955160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
